Diabetes

Papers
(The H4-Index of Diabetes is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
1151-P: Differential Associations between Plasma Lipids and Insulin Resistance in Women with and without Type 1 Diabetes121
252-OR: Virtual Multidisciplinary Lifestyle Intervention Is as Effective as the Physical Program for Patients with Diabetes and Obesity during COVID-19 Pandemic101
935-P: Favorable Shift in CGM Glucose in Youth with T1D during COVID-19 Pandemic93
31-OR: ACSL1 in Smooth Muscle Cells Regulates High-Fat Diet-Induced Obesity and Thermogenesis in Mice70
92-OR: Increased Disease Detection, Yet Treatment Barriers Identified, with Point-of-Care Retinopathy Screening65
962-P: Plasma Beta Hydroxybutyrate in Pregnancy and Gestational Diabetes65
619-P: Comparison of Dexcom G6 Continuous Glucose Monitoring and Point-of-Care Blood Glucose Testing in Hospitalized Patients with Diabetes59
1159-P: One-Hour Glucose during Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse in Black Obese Patients with Hyperglycemic Crises55
1152-P: Elucidating Protective Mechanisms of Targeting of hOGG1 to Mitochondria on the HFD-Induced Insulin Resistance in Mice Lacking OGG153
1278-PUB: Acid-Base Alterations after Isotonic Fluid Resuscitation of Patients in Suspected DKA in the Pediatric Emergency Department53
Deoxysphingolipids – atypical skeletal muscle lipids related to insulin resistance in humans that decrease insulin sensitivity in vitro53
1239-P: Evidence of Altered Alpha- and Beta-Cell Lysosomes prior to Onset of Type 1 Diabetes52
545-P: Experiences of Emerging Adults with T1D during the COVID-19 Pandemic52
797-P: Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-WECAN Study51
201-OR: Remission of Type 2 Diabetes and Decreased Inflammatory Markers with a High-Protein Diet51
363-P: The Ceramide- and Phosphatidylcholine-Based Coronary Event Risk Test 2 (CERT2) and Cardiovascular Mortality in Men and Women with Type 2 Diabetes50
1181-P: Consumption of Naturally Enriched Complex Carbohydrate Meal Improves Insulin Sensitivity and Disposition Index in Type 2 Diabetes50
778-P: SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors and Risk of All-Cause Hospitalization49
145-OR: Annual Wellness Visits Are Associated with Increased Use of Diabetes Preventive Services in the Diabetes Belt and Surrounding Counties47
389-P: Pathological Significance of Renal Tubular ROCK2 in Chronic Kidney Disease47
203-LB: Boosted Beta-Cell Function with Selective Deletion of the Adaptor Protein Mig646
101-OR: Efficacy and Safety of Once-Weekly Semaglutide 2.0 vs. 1.0 mg for Type 2 Diabetes: SUSTAIN FORTE Randomized Trial46
607-P: Glycemic Metrics in Japanese Flash Glucose Monitoring Users by Diabetes Type and Therapy46
163-LB: Differences in Maternal and Fetal Outcomes by CGM Use in a T1D Specialty Clinic43
910-P: Psychosocial Characteristics Associated with Diabetes Device Use in Teens with T1D43
923-P: CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Insulin Lispro Increases Time in Range Compared with Standard Insulin Lispro in Adults with Type 1 Diabetes—A Double-Blind, Randomized, Crossover S42
639-P: GIP Receptor Agonism Enhances Weight Loss from Either a Biased or an Unbiased GLP-1 Receptor Agonist in DIO Mice42
246-OR: Probing the Role of Alternative Splicing of IKZF1 in Risk for Type 1 Diabetes41
204-OR: An Early Immune Signature in Prediabetes Can Predict Progression to Type 2 Diabetes41
Issues and Events41
Issues and Events41
Issues and Events39
Issues and Events38
153-OR: Measurement of C-Peptide at Diagnosis Informs Glycemic Control but Not Hypoglycemic Risk in Type 1 Diabetes37
Issues and Events37
507-P: Effectiveness of a Ketogenic Diet and Virtual Coaching Intervention for Patients with Diabetes: A Difference-in-Differences Analysis37
1169-P: PNPLA3 148M Is More Susceptible to PA-Induced Endoplasmic Reticulum Stress-Associated Apoptosis in HepG2 Cells36
0.034018039703369